Complex Coronary Interventions | Monday Session (Non-CME)

Monday, February 27, 2023

2:00 PM – 5:33 PM ET

Program Director(s)

Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose
Lowell Satler, MD, FSCAI

Director of the Cardiac Cath Lab
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Gregg Stone, MD, FACC, MSCAI (he/him/his)

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure information not submitted.

Disclosure(s):

Lowell F. Satler, MD, FSCAI: No financial relationships to disclose

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)